Document is current
Any future updates will be listed below
-
Authors
Tsuji, Katsunori https://orcid.org/0000-0003-0508-6774
Matsuoka, Yutaka J. https://orcid.org/0000-0002-8690-8129
Kuchiba, Aya
Suto, Akihiko
Ochi, Eisuke https://orcid.org/0000-0002-2497-0250
-
Funding
Funding for this research was provided by:
National Cancer Center Research and Development Fund (30-A-17)
Japan Society for the Promotion of Science (21J01471)
- License Information
-
More Information
Article History
Received: 4 September 2021
Accepted: 3 January 2022
First Online: 17 January 2022
Declarations
:
: This study was approved by the Institutional Review Board of the National Cancer on 28 February 2019 (ID: 2018–274).
: Informed consent was obtained from all individual participants included in the study.
: Patients signed informed consent regarding publishing their data.
: The authors declare that EO and KT have no conflicts of interest associated with this manuscript. YM has received speaker fees from Suntory, Pfizer, Mochida, Eli Lilly, and Cimic, is conducting collaborative research with SUSMED, and has received a grant from SENSHIN Medical Research Foundation. AK has received speaker fees from Chugai Pharmaceutical Co., Ltd.
